Agilent Technologies A Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Agilent CrossLab | $3.02B+1.5% | $2.97B+2.1% | $2.91B+1.7% | $2.86B+1.9% | $2.81B+1.8% | |
| Applied Markets | $1.38B+3.2% | $1.34B+1.8% | $1.31B+1.0% | $1.3B+1.7% | $1.28B-0.3% | |
| Life Sciences and Diagnostics Markets | $2.84B+2.8% | $2.76B+1.2% | $2.73B+3.7% | $2.63B+3.3% | $2.54B+2.0% | |
| Net revenue by Product | ||||||
| Instrumentation | $2.53B+2.8% | $2.46B+1.4% | $2.43B+1.4% | $2.39B+1.8% | $2.35B+0.1% | |
| Non-Instrumentation and Other | $4.7B+2.1% | $4.61B+1.9% | $4.52B+2.9% | $4.39B+2.7% | $4.28B+2.2% | |
| Services and Other | $2.1B+2.3% | $2.05B+2.2% | $2B+2.5% | $1.96B+2.7% | $1.9B+1.8% | |
| Net revenue by Geography | ||||||
| Americas | $2.9B+3.1% | $2.82B+0.3% | $2.81B+3.5% | $2.71B+2.1% | $2.65B+1.6% | |
| Asia Pacific | $2.28B+0.2% | $2.27B+2.4% | $2.22B-0.4% | $2.23B+2.0% | $2.18B+1.8% | |
| Europe | $2.05B+3.8% | $1.98B+2.9% | $1.92B+3.9% | $1.85B+3.4% | $1.79B+0.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Agilent Technologies break its business down?
- Agilent Technologies (A) reports net revenue by business across 3 parts — Agilent CrossLab, Applied Markets and Life Sciences and Diagnostics Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Agilent Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Agilent Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
